ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study to Evaluate the Effect of Two Different Repeat Doses of GSK2190915 on the QTc Interval.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01721135
Recruitment Status : Withdrawn (Study was terminated due to toxicology findings after screening started but before first subject first dose.)
First Posted : November 5, 2012
Last Update Posted : August 21, 2013
Sponsor:
Information provided by (Responsible Party):
GlaxoSmithKline

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Estimated Primary Completion Date : December 2014
  Estimated Study Completion Date : December 2014